Agreement for the reservation of manufacturing capacity and production and supply of influenza pandemic specific vaccine during a pandemic.
key details
| Value | £1 |
|---|---|
| Status | complete |
| Category (CPV) | 33651660 |
| Deadline | 14 Mar 2022 |
| Contract start | 1 Sept 2023 |
| Contract end | 31 Aug 2027 |
| Procedure | selective |
| SME suitable | No |
| OCID | ocds-b5fd17-61b7f750-eea3-4b49-8b6a-ee31a41b7d04 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| SEQIRUS UK LIMITED | £1 | 29 Aug 2023 | active |
description
Agreement for the reservation of manufacturing capacity and production and supply of influenza pandemic specific vaccine during a pandemic.
Additional information:
The contract has the option to be extended for up to 6 years in fixed increments of 2 years at a time (i.e. 4+2+2+2). The total contract term including any extensions will not exceed 10 years.
Information on the contract value has been withheld pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interests of the supplier.
The contract is for the benefit of the Authority & NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments & their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies & British Overseas Territories including without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies & British Overseas Territories to undertake their respective vaccination programmes.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 2 Oct 2023 | Award (award) | · | ba406f16-db97-484b-b7ce-9f9f19d3dd5f-685424 |
more from Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency
- RSV immunisations (2024) · 24 Jan 2024
- Pralidoxime chloride 2024 · 22 Nov 2023
- Pneumococcal conjugate vaccine (PCV) 2024 · 27 Jul 2023
- Tuberculin purified protein derivative (PPD) 2024 · 2 Mar 2023
- DTaP/IPV 2024 · 11 Jan 2023
- Advanced Purchase Agreement for Pandemic Specific Vaccines · 23 Aug 2022
- BCG 2023 · 6 Jul 2022
- Ciprofloxacin and doxycycline 2022-2023 · £1 · 10 Feb 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Live Attenuated Influenza vaccine 2026/2027 · UK Health Security Agency · £225,408,000
- Live Attenuated Influenza Vaccine 2026/2027 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Inactivated influenza vaccine for children 2025 · UK Health Security Agency · £1
- Inactivated influenza vaccine for children 2025 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £1
- Influenza Vaccine Season 2025 · Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of Welsh Government) · £36,764,227
- The Supply of Influenza Vaccines · Ministry of Defence · £2,600,000
- DHSC: GOps: HR Flu Vouchers 2024-2025 · DHSC · £20,600
- The Supply of Influenza Vaccines · Leidos Supply · £2,600,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.